The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades

The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades

Abstract Progress in the research and therapy of adult acute lymphoblastic leukemia (ALL) is accelerating. This analysis summarizes the data derived from the clinical trials conducted at MD Anderson between 1985 and 2022 across ALL subtypes. In Philadelphia chromosome-positive ALL, the addition of B...

Full description

Bibliographic Details
Main Authors: Elias Jabbour, Nicholas J. Short, Nitin Jain, Fadi G. Haddad, Mary Alma Welch, Farhad Ravandi, Hagop Kantarjian
Format: Article
Language:English
Published: BMC 2023-03-01
Series:Journal of Hematology & Oncology
Subjects:
Blinatumomab
CAR T cell
Chemotherapy-free
Cure
Evolution
Inotuzumab
Online Access:https://doi.org/10.1186/s13045-023-01409-5

Similar Items

Similar Items